RIL
IRMD icon

Rothschild Investment LLC’s iRadimed IRMD Stock Holding History

Rothschild Investment LLC’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191 Sell
2
-7
-78% -$638 ﹤0.01% 3443
2026
Q1 		$866 Buy
9
+6
+200% +$600 ﹤0.01% 2929
2025
Q4 		$292 Buy
+3
New +$257 ﹤0.01% 3052

Other funds holding IRMD

CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
SI
Shaker Investments Cleveland, Ohio $278M AUM 69.83% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DCM
Davidson Capital Management Corpus Christi, Texas $624M AUM 29.17% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
IP
Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Rothschild Investment LLC's IRMD Position: Q2 2026 in Review

Rothschild Investment LLC reduced its iRadimed (IRMD) stake by 78% in Q2 2026, selling an estimated $638 and leaving 2 shares worth $191. The position accounts for ﹤0.01% of the portfolio, ranked #3443.

Rothschild Investment LLC first reported a position in IRMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $866 in Q1 2026. 67 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Rothschild Investment LLC held 2 shares of iRadimed worth $191 as of Q2 2026.
  • Rothschild Investment LLC sold 7 iRadimed shares in Q2 2026, an estimated $638.
  • iRadimed made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3443 holding.
  • Rothschild Investment LLC first reported a position in iRadimed in Q4 2025 and has held it in 3 quarters since.
  • Rothschild Investment LLC's iRadimed position peaked at $866 in Q1 2026.
  • 67 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.